Security
Cybin Inc. Common Stock · HELP
HELPNASDAQCommon stockCurrentCIK 1833141Updated Oct 9, 2026
Name history
CYBIN INC. · through Sep 23, 2026
HELP price & chart
Loading TradingView…
NASDAQ:HELP on TradingView ↗In the news
Helus Pharma Announces Completion of Legal Name Change ↗
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time ↗
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · CADcash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossCAD | -113,137,000Source | -78,080,000Source | -47,490,000Source | -67,631,000Source |
| Additional Financial Items | ||||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableCAD | -1,409,000Source | -1,089,000Source | -948,000Source | -773,000Source |
| AdjustmentsForSharebasedPaymentsCAD | 42,869,000Source | 13,886,000Source | 4,686,000Source | 18,030,000Source |
| GeneralAndAdministrativeExpenseCAD | 45,368,000Source | 32,588,000Source | 21,341,000Source | 28,222,000Source |
| GoodwillCAD | 51,487,000Source | 47,475,000Source | 24,792,000Source | 22,892,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesCAD | 290,000Source | 149,000Source | — | — |
| ProceedsFromIssuingSharesCAD | 20,487,000Source | 254,600,000Source | 13,202,000Source | 31,507,000Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesCAD | — | 689,000Source | 3,167,000Source | 415,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | — |
| Total RevenueCAD | — | — | — | 0Source |
| Additional Financial Items | ||||
| BasicEarningsLossPerShareCAD/shares | -5.59Source | -0.25Source | -0.26Source | -0.4Source |
| DilutedEarningsLossPerShareCAD/shares | — | — | -0.26Source | -0.4Source |
| EmployeeBenefitsExpenseCAD | 13,146,000Source | 8,248,000Source | 6,272,000Source | 7,468,000Source |
| GeneralAndAdministrativeExpenseCAD | 45,368,000Source | 32,588,000Source | 21,341,000Source | 28,222,000Source |
| GrossProfitCAD | — | — | — | 0Source |
| ImpairmentLossRecognisedInProfitOrLossGoodwillCAD | 0Source | 0Source | — | 0Source |
| IncomeTaxExpenseContinuingOperationsCAD | 0Source | 0Source | 0Source | 0Source |
| InterestExpenseOnLeaseLiabilitiesCAD | 7,000Source | 8,000Source | — | — |
| OtherIncomeCAD | 30,010,000Source | 756,000Source | 4,028,000Source | — |
| ProfessionalFeesExpenseCAD | 4,156,000Source | 4,918,000Source | 2,142,000Source | 3,275,000Source |
| ResearchAndDevelopmentExpenseCAD | 54,910,000Source | 32,362,000Source | 25,491,000Source | 17,586,000Source |
| RevenueFromInterestCAD | 8,289,000Source | 619,000Source | 603,000Source | 241,000Source |
Filing attachments
d12151893_ex99-1.htm · SCHEDULE 13G · 2026-05-15
EXHIBIT 99.1 JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the …
Read attachment ↗